anticoagulation [topp]
Secondary Prevention [topp]
Drug [phsu]
Thromboembolic events [patf]
Major [qlco]
Complication [patf]
Cardiovascular Diseases [dsyn]
Secondary Prevention [topp]
thromboembolic [ftcn]
Complications [patf]
Heparin [bacs, carb, phsu]
Vitamin K antagonists [phsu]
New [tmco]
Class [inpr]
Direct Thrombin Inhibitors [aapp, bacs, phsu]
Recently [tmco]
introduce [ftcn]
Clinical Medicine [bmod]
Clinical Studies [resa]
Agent [chvf]
Efficacy [qlco]
prophylaxis [inpr]
Venous Thromboembolism [patf]
Result [ftcn]
ONGOING [idcn]
Trial [resa]
Place [spco]
Direct Thrombin Inhibitors [aapp, bacs, phsu]
Secondary Prevention [topp]
antiplatelet therapy [topp]
Management [ocac]
Patients [podg]
Syndromes, Acute Coronary [dsyn]
High Risk [qlco]
Patients [podg]
Recently [tmco]
Long-term [tmco]
Term [tmco]
antiplatelet therapy [topp]
treatment [ftcn]
Prevention [topp]
Disease [dsyn]
Limited [ftcn]
Aspirin [orch, phsu]
thienopyridines [orch, phsu]
Glycoprotein IIb/IIIa [aapp, imft, rcpt]
inhibitors [chvf]
Represent [acty]
Addition [ftcn]
Physician [prog]
Arma [euka]
Increased [qnco]
Risk [qlco]
Major [qlco]
Bleeding [patf]
Decision [menp]
anticoagulation [topp]
antiplatelet therapy [topp]
Correlated [qlco]
Individual [popg]
benefit risk [qlco]
Ratio [qnco]
